Vitamin K2 stimulates MC3T3‑E1 osteoblast differentiation and mineralization through autophagy induction

Li,Weiwei; Zhang,Shaokun; Liu,Jie; Liu,Yongyi; Liang,Qingwei

doi:10.3892/mmr.2019.10040

Vitamin K2 stimulates MC3T3‑E1 osteoblast differentiation and mineralization through autophagy induction

Authors:
- Weiwei Li
- Shaokun Zhang
- Jie Liu
- Yongyi Liu
- Qingwei Liang
View Affiliations

Affiliations: Department of Orthopedics, The First Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China, Science Experiment Center of China Medical University, Shenyang, Liaoning 110122, P.R. China, Department of Sports Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China
Published online on: March 15, 2019 https://doi.org/10.3892/mmr.2019.10040
Pages: 3676-3684
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vitamin K2 likely exerts its protective effects during osteoporosis by promoting osteoblast differentiation and mineralization. However, the precise mechanism remains to be fully elucidated. Autophagy maintains cell homeostasis by breaking down and eliminating damaged proteins and organelles. Increasing evidence in recent years has implicated autophagy in the development of osteoporosis. The aim of the present study was to verify whether vitamin K2 (VK2) can induce autophagy during the differentiation and mineralization of osteoblasts. In the present study, MC3T3‑E1 osteoblasts were treated with various doses of VK2 (10‑8‑10‑3 M) for 1‑5 days. The results revealed no cytotoxicity at concentrations below 10‑5 M, but cell viability was reduced in a dose‑dependent manner at concentrations above 10‑5 M. Furthermore, MC3T3‑E1 osteoblasts were seeded in 6‑well plates in complete medium supplemented with dexamethasone, β‑glycerophosphate and vitamin C (VC) for osteogenic differentiation. MC3T3‑E1 osteoblasts treated with different concentrations (10‑5, 10‑6 and 10‑7 M) of VK2 for 24 h on days 1, 3, 5 and 7 of the differentiation protocol. It was confirmed that VK2 promoted osteoblast differentiation and mineralization by using alkaline phosphatase (ALP) and alizarin red staining. Using western blotting, immunofluorescence, monodansylcadaverine staining and reverse transcription‑quantitative polymerase chain reaction, it was observed that VK2 induced autophagy in osteoblasts. The results revealed that VK2 (1 µM) significantly increased ALP activity and the conversion of microtubule associated protein 1 light chain 3‑α (LC3)II to LC3I in MC3T3‑E1 osteoblasts (P<0.05) at every time point. The number of fluorescent bodies and the intensity increased with VK2, and decreased following treatment with 3‑MA+VK2. There was an increase in the mRNA expression levels of ALP, osteocalcin (OCN) and Runt‑related transcription factor 2 in VK2‑treated cells (P<0.01). The present study further confirmed the association between autophagy and osteoblast differentiation and mineralization through treatment with an autophagy inhibitor [3‑methyladenine (3‑MA)]. Osteoblasts treated with 3‑MA exhibited significant inhibition of ALP activity and osteogenic differentiation (both P<0.05). In addition, ALP activity and osteogenesis in the VK2+3‑MA group was lower compared with VK2‑treated cells (P<0.05 for both). The present study confirmed that VK2 stimulated autophagy in MC3T3 cells to promote differentiation and mineralization, which may be a potential therapeutic target for osteoporosis.

View Figures

View References

1	Tella SH and Gallagher JC: Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 142:155–170. 2014. View Article : Google Scholar : PubMed/NCBI
2	Glaser DL and Kaplan FS: Osteoporosis. Definition and clinical presentation. Spine (Phila Pa 1976). 22 (24 Suppl):12S–16S. 1997. View Article : Google Scholar : PubMed/NCBI
3	Edwards MH, Dennison EM, Aihie Sayer A, Fielding R and Cooper C: Osteoporosis and sarcopenia in older age. Bone. 80:126–130. 2015. View Article : Google Scholar : PubMed/NCBI
4	Diab DL and Watts NB: Postmenopausal osteoporosis. Curr Opin Endocrinol Diabetes Obes. 20:501–509. 2013. View Article : Google Scholar : PubMed/NCBI
5	Clarke BL: Anti-sclerostin antibodies: Utility in treatment of osteoporosis. Maturitas. 78:199–204. 2014. View Article : Google Scholar : PubMed/NCBI
6	Levine JP: Identification, diagnosis, and prevention of osteoporosis. Am J Manag Care. 17 (Suppl 6):S170–S176. 2011.PubMed/NCBI
7	Palermo A, Tuccinardi D, D'Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R, Napoli N, Pozzilli P and Manfrini S: Vitamin K and osteoporosis: Myth or reality? Metabolism. 70:57–71. 2017. View Article : Google Scholar : PubMed/NCBI
8	Nelsestuen GL, Zytkovicz TH and Howard JB: The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem. 249:6347–6350. 1974.PubMed/NCBI
9	Stenflo J, Fernlund P, Egan W and Roepstorff P: Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA. 71:2730–2733. 1974. View Article : Google Scholar : PubMed/NCBI
10	Berkner KL: The vitamin K-dependent carboxylase. Annu Rev Nutr. 25:127–149. 2005. View Article : Google Scholar : PubMed/NCBI
11	Hauschka PV, Lian JB and Gallop PM: Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA. 72:3925–3929. 1975. View Article : Google Scholar : PubMed/NCBI
12	Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD and Galipeau J: Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem. 283:17991–18001. 2008. View Article : Google Scholar : PubMed/NCBI
13	Rubinacci A: Expanding the functional spectrum of vitamin K in bone. Focus on: ‘Vitamin K promotes mineralization, osteoblast to osteocyte transition, and an anti-catabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms’. Am J Physiol Cell Physiol. 297:C1336–1338. 2009. View Article : Google Scholar : PubMed/NCBI
14	Atkins GJ, Welldon KJ, Wijenayaka AR, Bonewald LF and Findlay DM: Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms. Am J Physiol Cell Physiol. 297:C1358–1367. 2009. View Article : Google Scholar : PubMed/NCBI
15	Pierrefite-Carle V, Santucci-Darmanin S, Breuil V, Camuzard O and Carle GF: Autophagy in bone: Self-eating to stay in balance. Ageing Res Rev. 24:206–217. 2015. View Article : Google Scholar : PubMed/NCBI
16	Parzych KR and Klionsky DJ: An overview of autophagy: Morphology, mechanism, and regulation. Antioxid Redox Signal. 20:460–473. 2014. View Article : Google Scholar : PubMed/NCBI
17	White E, Mehnert JM and Chan CS: Autophagy, Metabolism, and Cancer. Clin Cancer Res. 21:5037–5046. 2015. View Article : Google Scholar : PubMed/NCBI
18	Mizushima N and Levine B: Autophagy in mammalian development and differentiation. Nat Cell Biol. 12:823–830. 2010. View Article : Google Scholar : PubMed/NCBI
19	Mizushima N, Levine B, Cuervo AM and Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
20	Yamaguchi M: The role of regucalcin in bone homeostasis: Involvement as a novel cytokine. Integr Biol (Camb). 6:258–266. 2014. View Article : Google Scholar : PubMed/NCBI
21	Raouf A and Seth A: Ets transcription factors and targets in osteogenesis. Oncogene. 19:6455–6463. 2000. View Article : Google Scholar : PubMed/NCBI
22	Yamaguchi M and Weitzmann MN: Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. Int J Mol Med. 27:3–14. 2011.PubMed/NCBI
23	Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B and Inoue S: Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J Mol Endocrinol. 39:239–247. 2007. View Article : Google Scholar : PubMed/NCBI
24	Zhang YL, Yin JH, Ding H, Zhang W, Zhang CQ and Gao YS: Protective effect of VK2 on glucocorticoid-treated MC3T3-E1 cells. Int J Mol Med. 39:160–166. 2017. View Article : Google Scholar : PubMed/NCBI
25	Nollet M, Santucci-Darmanin S, Breuil V, Al-Sahlanee R, Cros C, Topi M, Momier D, Samson M, Pagnotta S, Cailleteau L, et al: Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy. 10:1965–1977. 2014. View Article : Google Scholar : PubMed/NCBI
26	Chen K, Yang YH, Jiang SD and Jiang LS: Decreased activity of osteocyte autophagy with aging may contribute to the bone loss in senile population. Histochem Cell Biol. 142:285–295. 2014. View Article : Google Scholar : PubMed/NCBI
27	Pan F, Liu XG, Guo YF, Chen Y, Dong SS, Qiu C, Zhang ZX, Zhou Q, Yang TL, Guo Y, et al: The regulation-of-autophagy pathway may influence Chinese stature variation: Evidence from elder adults. J Hum Genet. 55:441–447. 2010. View Article : Google Scholar : PubMed/NCBI
28	Jilka RL, Weinstein RS, Parfitt AM and Manolagas SC: Quantifying osteoblast and osteocyte apoptosis: Challenges and rewards. J Bone Miner Res. 22:1492–1501. 2007. View Article : Google Scholar : PubMed/NCBI
29	Li L, Tan J, Miao Y, Lei P and Zhang Q: ROS and Autophagy: Interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 35:615–621. 2015. View Article : Google Scholar : PubMed/NCBI
30	Liu F, Fang F, Yuan H, Yang D, Chen Y, Williams L, Goldstein SA, Krebsbach PH and Guan JL: Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res. 28:2414–2430. 2013. View Article : Google Scholar : PubMed/NCBI
31	Xi G, Rosen CJ and Clemmons DR: IGF-I and IGFBP-2 stimulate AMPK activation and autophagy, which are required for osteoblast differentiation. Endocrinology. 157:268–281. 2016. View Article : Google Scholar : PubMed/NCBI
32	Chang KH, Sengupta A, Nayak RC, Duran A, Lee SJ, Pratt RG, Wellendorf AM, Hill SE, Watkins M, Gonzalez-Nieto D, et al: p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-kB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche. Cell Rep. 9:2084–2097. 2014. View Article : Google Scholar : PubMed/NCBI
33	Liu Y, Huang L, Hao B, Li H, Zhu S, Wang Q, Li R, Xu Y and Zhang X: Use of an osteoblast overload damage model to probe the effect of icariin on the proliferation, differentiation and mineralization of MC3T3-E1 cells through the Wnt/β-catenin signalling pathway. Cell Physiol Biochem. 41:1605–1615. 2017. View Article : Google Scholar : PubMed/NCBI
34	Kim EC, Kim TH, Jung JH, Hong SO and Lee DW: Enhanced osteogenic differentiation of MC3T3-E1 on rhBMP-2-immobilized titanium via click reaction. Carbohydr Polym. 103:170–178. 2014. View Article : Google Scholar : PubMed/NCBI
35	He Y, Wang S, Mu J, Dai L, Zhang Z, Sun Y, Shi W and Ge D: Synthesis of polypyrrole nanowires with positive effect on MC3T3-E1 cell functions through electrical stimulation. Mater Sci Eng C Mater Biol Appl. 71:43–50. 2017. View Article : Google Scholar : PubMed/NCBI
36	Mu W and Wang Z, Ma C, Jiang Y, Zhang N, Hu K, Li L and Wang Z: Metformin promotes the proliferation and differentiation of murine preosteoblast by regulating the expression of sirt6 and oct4. Pharmacol Res. 129:462–474. 2018. View Article : Google Scholar : PubMed/NCBI